SP
MDSO

Sarasin & Partners’s Medidata Solutions, Inc. MDSO Stock Holding History

Sarasin & Partners’s Portfolio MDSO Stock Details MDSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-42,220
Closed -$3.82M – 130
2019
Q2 		$3.82M Buy
+42,220
New +$3.7M 0.07% 101

Other funds holding MDSO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
SCS
Syquant Capital SAS Paris, France $447M AUM 13.04% 1-Year Est. Return

Sarasin & Partners's MDSO Position: Q3 2019 in Review

Sarasin & Partners sold out of Medidata Solutions, Inc. (MDSO) in Q3 2019, closing a stake of 42,220 shares — an estimated $3.82M sold.

Sarasin & Partners first reported a position in MDSO in Q2 2019 and held it in 1 quarter. The position peaked at $3.82M in Q2 2019. 281 funds tracked by Wall St. Rank hold MDSO as of Q3 2019.

  • Sarasin & Partners reported no remaining Medidata Solutions, Inc. position as of Q3 2019 after selling out during the quarter.
  • Sarasin & Partners sold 42,220 Medidata Solutions, Inc. shares in Q3 2019, an estimated $3.82M.
  • Sarasin & Partners first reported a position in Medidata Solutions, Inc. in Q2 2019 and held it in 1 quarter.
  • Sarasin & Partners's Medidata Solutions, Inc. position peaked at $3.82M in Q2 2019.
  • 281 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q3 2019.

Based on Sarasin & Partners's 13F filing for Q3 2019, filed 8 Nov 2019.